Watson Pharmaceuticals, Inc. (NYSE:WPI)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $57.90 |
| Daily Range | $57.35 - $58.29 |
| 52-Week Range | $53.73 - $73.35 |
| Market Cap | $7.81B |
| P/E Ratio | 59.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,197,668 |
| Average Daily Volume | 0 |
WPI
VS S&P 500 (SPY)
How do you think WPI will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
WPI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
WPI News and Commentary
- WellPoint To Cease Branded Lipitor Coverage, Favor Generics – SmartMoney
- Amgen Upped to Outperform - Analyst Blog – NASDAQ
- Top Stocks at Half-Price – The Motley Fool
- UPDATE: Pfizer 4Q Profit Slumps 50% As Lipitor Sales Decline – SmartMoney
- Watson in an Upbeat Mood - Analyst Blog – NASDAQ
- These 2 Stocks Will Move the Dow Tomorrow – The Motley Fool
- UPDATE: Express Scripts' Lipitor Move Highlights Pressure On Pfizer – SmartMoney
- Benefit Manager's Lipitor Move Highlights Pressure On Pfizer – SmartMoney
- US Court Stays Momenta Injunction Against Generic Lovenox – SmartMoney
- Watson's Impressive Prelim Results - Analyst Blog – NASDAQ
- Watson Buys Ascent Pharmahealth - Analyst Blog – NASDAQ
- Watson's Drug Fails to Get Support - Analyst Blog – NASDAQ
- Columbia Labs Fails to Impress FDA – Blogs @ The Motley Fool
- Watson Increases Generic Count - Analyst Blog – NASDAQ
- FDA Staff Critical of Treatment to Reduce Preterm Births – Minyanville
- Shire, Prasco Ink Deal - Analyst Blog – NASDAQ
- Making Cents in Penny Stocks – The Motley Fool
- Teva Sees Limited Competition For Biosimilar Market – SmartMoney
- A Hidden Reason the Future Looks Bright for Watson Pharmaceuticals – The Motley Fool
- Sabrient Systems To Unveil 'Baker's Dozen' Of Expected Top Stocks In 2012 – SmartMoney
RSS Headlines
Fool UK
